2024-02-20 20:39:10 ET
Teladoc Health, Inc. (TDOC)
Q4 2023 Earnings Conference Call
February 20, 2024 05:00 AM ET
Company Participants
Patrick Feeley - Head of Investor Relations
Jason Gorevic - Chief Executive Officer
Mala Murthy - Chief Financial Officer
Conference Call Participants
Lisa Gill - JPMorgan
Stephanie Davis - Barclays
Jailendra Singh - Truist
Richard Close - Canaccord Genuity
Jessica Tassan - Piper Sandler
Charles Rhyee - TD Cowen
George Hill - Deutsche Bank
Sean Dodge - RBC Capital
Ryan Daniels - William Blair
Daniel Grosslight - Citi
Presentation
Operator
Good afternoon, ladies and gentlemen. Thank you for joining today's Teladoc Health Q4 Earnings Call. My name is Tia, and I'll be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions-and-answers at the end. [Operator Instructions]
I'd now like to pass the call over to Patrick Feeley, Head of Investor Relations. Please proceed.
Patrick Feeley
Thank you, and good afternoon. Today after the market closed, we issued a press release announcing our fourth quarter and full year 2023 financial results. This press release and the accompanying slide presentation are available in the investor relations section of the teladochealth.com. website. On this call to discuss the results are Jason Gorevic, Chief Executive Officer; and Mala Murthy, Chief Financial Officer.
During this call we will also discuss our forward outlook and our prepared remarks will be followed by a question-and-answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most comparable GAAP measures, and reconciliations thereof, can be found in the press release that is posted on our website.
Also, please note that certain statements made during this call will be forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause the actual results for Teladoc Health to differ materially from those expressed or implied in this call. For additional information, please refer to our cautionary statement on our press release and our filings with the SEC, all of which are available on our website....
Read the full article on Seeking Alpha
For further details see:
Teladoc Health, Inc. (TDOC) Q4 2023 Earnings Call Transcript